Table 3.

Patients included in all 3 low-response groups (n = 11)

USI	Age (years)	Sex	BM blast%	Cytogenetics	FLT3	Mutations	Risk assignment	SCT in CR1?	First event
PANXWX	7.5921	F	81	t(9;11) ( +)	WT	None	Standard	Unknown	Induction failure
PAPBEJ	1.0048	F	50	del(7q)( +)	WT	None	Standard	No	Relapse
PARWXU	1.526	M	91% (PB)	del(11p)	WT	None	Standard	No	Relapse
PARXMP	1.463	M	35	Complex; NUP98-KDM5A	WT	None	Standard	No	Censored
PASLTF	16.8569	M	81	NK	WT	CEBPα	Low	No	Censored
PASMYS	2.1027	F	47	+ 8	WT	NPM1, WT1, KIT	Low	No	Relapse
PASXDS	15.6797	M	37	NK	PM	NPM1	Low	No	Censored
PASXVC	20.3751	M	71	NK	ITD 0.37	NPM1	Low	Yes	Relapse
PASYDA	13.9329	M	32	NK	ITD 0.19	NPM1	Low	Yes	Death in CR
PASYWA	14.1848	M	95	NK	ITD 0.93	None	High	Unknown	Induction failure
PATGIY	5.321	M	66	t(6;11)	WT	None	Standard	Yes	Relapse

USI unique subject identifier, WT wild-type, ITD internal tandem duplication, PM point mutation, SCT stem cell transplant, CR1 first complete remission